Advances in the treatment of advanced melanoma with NRAS gene mutation

Oncogenic mutations are responsible for a majority of the malignancy of melanoma. Activating mutations of NRAS gene are found in 15%-20% melanoma cases, endowing the tumor cells with more aggressive phenotypes and greater difficulty to treat. The development of targeted inhibitor of mutant NRAS rema...

Full description

Bibliographic Details

Published in:	Zhongguo aizheng zazhi
Main Author:	ZHAO Bolun, ZHU Guannan
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2023-10-01
Subjects:	|nras mutation|melanoma|carcinogenesis|targeted therapy
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1698723448742-951764022.pdf